Data as of May 24
| +0.34 / +1.65%|
The 7 analysts offering 12-month price forecasts for Isis Pharmaceuticals Inc have a median target of 18.00, with a high estimate of 31.00 and a low estimate of 7.00. The median estimate represents a -14.20% decrease from the last price of 20.98.
The current consensus among 9 polled investment analysts is to Buy stock in Isis Pharmaceuticals Inc. This rating has held steady since May, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.